Combined Rod and Cone Transduction by Adeno-Associated Virus 2/8
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Gene transfer to both cone and rod photoreceptors (PRs) is essential for gene therapy of inherited retinal degenerations that are caused by mutations in genes expressed in both PR types. Vectors based on the adeno-associated virus (AAV) efficiently transduce PRs of different species. However, these are predominantly rods and little is known about the ability of the AAV to transduce cones in combination with rods. Here we show that AAV2/8 transduces pig cones to levels that are similar to AAV2/9, and the outer nuclear layer (mainly rods) to levels that are on average higher, although not statistically significant, than both AAV2/5 and AAV2/9. We additionally found that the ubiquitous cytomegalovirus (CMV), but not the PR-specific GRK1 promoter, transduced pig cones efficiently, presumably because GRK1 is not expressed in pig cones as observed in mice and humans. Indeed, the GRK1 and CMV promoters transduce a similar percentage of murine cones with the CMV reaching the highest expression levels. Consistent with this, the AAV2/8 vectors with either the CMV or the GRK1 promoter restore cone function in a mouse model of Leber congenital amaurosis type 1 (LCA1), supporting the use of AAV2/8 for gene therapy of LCA1 as well as of other retinal diseases requiring gene transfer to both PR types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 1×
“…administrations of AAV have been recently demonstrated in patients with Leber congenital amaurosis type 2 (LCA2) (Bainbridge et al., 2008; Cideciyan et al., 2008, 2009a,b, 2013; Hauswirth et al., 2008; Maguire et al., 2008, 2009; Simonelli et al., 2010; Ashtari et al., 2011; Testa et al., 2013).”
BackgroundSelf-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924 · cited 3×
“The ability of AAV to transduce retinal pigment epithelium (RPE), regardless of the serotype used (Vandenberghe and Auricchio, 2012), may partially explain these clinical successes as RPE65, the gene mutated in LCA2 patients, is indeed expressed in the RPE.”
BackgroundThe Major Cell Populations of the Mouse Retina
Jeon, C.-J., Strettoi, E., & Masland, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08936.1998 · Cited by 1,429
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865 · cited 1×
“…administrations of AAV have been recently demonstrated in patients with Leber congenital amaurosis type 2 (LCA2) (Bainbridge et al., 2008; Cideciyan et al., 2008, 2009a,b, 2013; Hauswirth et al., 2008; Maguire et al., 2008, 2009; Simonelli et al., 2010; Ashtari et al., 2011; Testa et al., 2013).”
Self-citationLeber congenital amaurosis: Genes, proteins and disease mechanisms
den Hollander, A. I., Roepman, R., Koenekoop, R. K., & Cremers, F. P. M. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.003 · Cited by 811 · cited 1×
“Mutations in GUCY2D (the human ortholog of Gucy2e) account for around 20% of all LCA cases (Perrault et al., 2000; den Hollander et al., 2008).”
BackgroundBeltran, W. A., Cideciyan, A. V., Lewin, A. S., Iwabe, S., Khanna, H., Sumaroka, A., Chiodo, V. A., Fajardo, D. S., Román, A. J., Deng, W.-T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118847109 · Cited by 260
Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors
Allocca, M., Mussolino, C., Garcia-Hoyos, M., Sanges, D., Iodice, C., Petrillo, M., Vandenberghe, L. H., Wilson, J. M., Marigo, V., Surace, E. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01327-07 · Cited by 246
Self-citationIdentification and Characterization of MicroRNAs Expressed in the Mouse Eye
Karali, M., Peluso, I., Marigo, V., & Banfi, S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0866 · Cited by 196 · cited 1×
“As an additional strategy to restrict transgene expression to PRs, we used the CMV promoter in combination with target sites of microRNA (miR) 204, which is expressed at higher levels in the RPE than in PRs (Karali et al., 2007).”
MethodDistribution and Density of Medium- and Short-wavelength Selective Cones in the Domestic Pig Retina
Hendrickson, A., & Hicks, D. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.1181 · Cited by 183
Research works printed but not linked: 41
- 10.1038/eye.1998.142 · DOI
- 10.1172/JCI57377 · DOI · Paper page
- 10.1074/jbc.M610369200 · DOI · Paper page
- 10.1073/pnas.96.17.9920 · DOI · Paper page
- Birch D.G., 1995, Invest. Ophthalmol. Vis. Sci., 36, 1603
- 10.1371/journal.pone.0011306 · DOI · Paper page
- 10.1167/iovs.11-7867 · DOI · Paper page
- 10.1089/hum.2012.125 · DOI · Paper page
- 10.1002/cne.901880204 · DOI · Paper page
- 10.1073/pnas.0807027105 · DOI · Paper page
- 10.1089/hum.2009.086 · DOI · Paper page
- 10.1056/NEJMc0903652 · DOI · Paper page
- 10.1073/pnas.1218933110 · DOI · Paper page
- 10.1034/j.1399-0004.2000.570501.x · DOI
- 10.1073/pnas.0705465104 · DOI · Paper page
- 10.1172/JCI42258 · DOI · Paper page
- Garbers D.L., 1994, J. Biol. Chem., 269, 30741, 10.1016/S0021-9258(18)47339-5 · DOI · Paper page
- 10.1093/hmg/dds421 · DOI · Paper page
- 10.1167/iovs.07-0257 · DOI · Paper page
- 10.1186/1479-0556-2-3 · DOI
- 10.1002/jgm.1126 · DOI · Paper page
- Li A., 2002, Invest. Ophthalmol. Vis. Sci., 43, 1375
- 10.1038/nature08401 · DOI · Paper page
- 10.1002/(SICI)1097-0029(19961215)35:6<463::AID-JEMT5>3.0.CO;2-J · DOI · Paper page
- 10.1089/hum.2011.069 · DOI · Paper page
- Omri S., 2010, Clin. Ophthalmol., 4, 183
- 10.1167/iovs.09-3734 · DOI · Paper page
- 10.1089/hum.2009.218 · DOI · Paper page
- 10.1038/sj.ejhg.5200503 · DOI
- 10.1038/mt.2012.134 · DOI · Paper page
- 10.1038/ncomms1540 · DOI
- 10.1038/mt.2009.277 · DOI · Paper page
- Stieger K., 2010, Discov. Med., 10, 425
- 10.1038/gt.2009.104 · DOI · Paper page
- 10.1007/s00431-011-1615-2 · DOI
- 10.1016/j.visres.2007.07.027 · DOI
- 10.1016/j.ophtha.2012.11.048 · DOI · Paper page
- 10.1126/scitranslmed.3002103 · DOI · Paper page
- Weiss E.R., 2001, J. Neurosci., 21, 9175, 10.1523/JNEUROSCI.21-23-09175.2001 · DOI · Paper page
- Yang R.B., 1999, J. Neurosci., 19, 5889, 10.1523/JNEUROSCI.19-14-05889.1999 · DOI · Paper page
- 10.1167/iovs.03-0197 · DOI · Paper page
Cited by
Pharmaceutical development of AAV-based gene therapy products for the eye
Rodrigues, G. A., Shalaev, E., Karami, T. K., Cunningham, J., Slater, N. K. H., & Rivers, H. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2554-7 · Cited by 213
Tornabene, P., Trapani, I., Minopoli, R., Centrulo, M., Lupo, M., de Simone, S., Tiberi, P., Dell’Aquila, F., Marrocco, E., Iodice, C., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav4523 · Cited by 192
Self-citationTriple Vectors Expand AAV Transfer Capacity in the Retina
Maddalena, A., Tornabene, P., Tiberi, P., Minopoli, R., Manfredi, A., Mutarelli, M., Rossi, S., Simonelli, F., Naggert, J. K., Cacchiarelli, D., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.019 · Cited by 128
Self-citationSeitz, I. P., Michalakis, S., Wilhelm, B., Reichel, F. F., Ochakovski, G. A., Zrenner, E., Ueffing, M., Biel, M., Wissinger, B., Bartz-Schmidt, K. U., et al. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-22473 · Cited by 108
Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors
Colella, P., Trapani, I., Cesi, G., Sommella, A., Manfredi, A., Puppo, A., Iodice, C., Rossi, S., Simonelli, F., Giunti, M., et al. (2014) · Gene Therapy · doi:10.1038/gt.2014.8 · Cited by 103
Self-citation
Metadata
- Authors
- Manfredi, A., Marrocco, E., Puppo, A., Cesi, G., Sommella, A., Della Corte, M., Rossi, S., Giunti, M., Craft, C. M., Bacci, M. L., Simonelli, F., Surace, E. M., & Auricchio, A.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2013-12
- Volume
- 24
- Issue
- 12
- Pages
- 982-992
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2063725045
- Cited by
- 43
- References
- 14
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined Rod and Cone Transduction by Adeno-Associated Virus 2/8. https://app.cochat.ai/papers/10.1089/hum.2013.154
- The paper
- Manfredi, A., Marrocco, E., Puppo, A., Cesi, G., Sommella, A., Della Corte, M., Rossi, S., Giunti, M., Craft, C. M., Bacci, M. L., Simonelli, F., Surace, E. M., & Auricchio, A. (2013). Combined Rod and Cone Transduction by Adeno-Associated Virus 2/8. Human Gene Therapy. https://doi.org/10.1089/hum.2013.154
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.